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Introduction: In order to target educational needs of patients more effectively, an Austrian-German educational
needs assessment tool (OENAT) was developed, the educational needs of patients with rheumatoid arthritis (RA),
psoriatic arthritis (PsA) and hand osteoarthritis (HOA) were described and the relationships between educational
needs, gender, disease activity and function were explored.
Methods: The English ENAT was adapted into Austrian-German using Beaton's cross-cultural adaptation process.
Internal construct validity was assessed by Rasch analysis. Educational needs across diagnostic groups and
subgroups of patients were summarized descriptively and their relationship with disease activity and physical
functioning explored.
Results: The sample comprised 130 RA, 125 PsA and 48 HOA patients. Their mean ages ± SD were 56 ± 14, 51 ± 11
and 64 ± 7 years for RA, PsA and HOA; disease duration was 11 ± 9, 11 ± 11 and 14 ± 9 years, respectively. More
than 70% in each patient group expressed interest in receiving education about their disease.
The educational needs differed significantly between women and men in all 3 groups. In RA and PsA, female patients
expressed significantly higher educational needs than men in ‘movements’ and ‘feelings’ domains (p=0.04 and p=0.03
for RA and p<0.01 and p=0.01 for PsA). Female patients in the HOA group had significantly higher scores on all
domains except for the ‘movements’. Older patients with PsA scored significantly higher than their younger
counterparts in the ‘pain’ domain (p=0.05). RA patients with disease duration >5 years), expressed higher educational
needs in ‘movements’ (p<0.01). Educational background had effects in the PsA group only, patients with basic
education had greater scores than those with higher education on ‘movements’ and ‘arthritis process’ (p=0.01).
In the RA group, DAS28 correlated significantly with ‘movements’ (r=0.24, p=0.01), ‘feelings’ (r=0.22, p=0.02), and
‘treatments’ (r=0.22, p=0.03). In the PsA group, all OENAT domains correlated with disease activity (DAPSA and CDAI).
Conclusions: This study showed that educational needs vary with personal characteristics. Patient education may be
more targeted and effective, if gender, age, educational background and disease duration are taken into account.
Correlations with disease activity and function suggest that the OENAT could enable identification of ‘intervention
points’, which can be ideal opportunities for effective patient education.* Correspondence: tanja.stamm@meduniwien.ac.at
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Rheumatoid arthritis (RA) is a common systemic inflamma-
tory disease characterized by the presence of destructive
polyarthritis with a predisposition for affecting the small
joints of the hand and feet [1]. RA leads to pain, swelling
and stiffness, limitations in joint function as well as struc-
tural joint damage that impedes functioning in daily activ-
ities [2]. Psoriatic arthritis (PsA) is likewise an inflammatory
joint disease that, aside from its association with psoriasis,
manifests clinically in several ways, including arthritis,
enthesitis, dactylitis, axial disease and skin/nail involvement
[3,4]. In contrast, osteoarthritis of the hands (HOA) is
regarded a non-inflammatory joint disease and constitutes
one of the most prevalent musculoskeletal diseases, leading
to pain in and around affected joints, as well as bony swell-
ing, stiffness, deformity and gradual loss of function [5].
However, HOA can also occur relatively early in life, impair-
ing the patient’s capacity to work [6]. All three above de-
scribed conditions are chronic disabling diseases with
impact on body functions, but also on daily activities and
participation in society including productivity and employ-
ment. Although there are many definitions of patient educa-
tion [7], they all indicate that it involves an interactive
process between patients and professionals, aims at enabling
patients’ participation in treatment and improve their cop-
ing strategies. As such, patients’ active participation in dis-
ease management and treatment of rheumatic diseases is
essential and patient education is recommended as an inte-
gral part of the treatment [8].
The Austrian health care system does not offer any form
of structured patient education to individuals with a rheum-
atic disease, and this role is left to the clinical groups and in-
dividual health professionals. As effective patient education
needs to be patient-centered and tailored to individual edu-
cational needs [9], it is essential to assess the educational
needs of patients before giving a specific type of education.
Currently, there is no German tool for assessing educational
needs of people with rheumatic diseases; furthermore the
educational needs of people with rheumatic diseases in
Austria have never been systematically explored. The Educa-
tional Needs Assessment Tool (the ENAT) exists in English
and in six other European languages [10]. The aim of our
study was to target educational needs of people with differ-
ent rheumatic diseases more effectively. The specific aims
were (i) to develop and validate an Austrian-German version
of the ENAT (the OENAT), (ii) to use the OENAT to ex-
plore educational needs of people with RA, PsA and HOA
and (iii) to search relationships between educational needs,
gender, age, disease activity and functional ability.
Methods
Design
This study was conducted in two phases: (1) a cross-
cultural adaptation and validation of the OENAT, and (2)a cross-sectional survey to explore the educational needs
of people with RA, PsA or HOA, their disease activity and
physical functioning. The adaptation into German
followed an established process for cross-cultural adapta-
tion of self-report measures [11], which involved (i) for-
ward translations carried out by two bilingual translators
whose mother tongue was German; (ii) synthesis of the
translations, carried out by the forward translators and the
recording observer producing (iii) back translations, car-
ried out by two other bilingual translators whose mother
tongue was English; (iv) the expert committee meeting to
review the translations, and (v) testing the pre-final
OENAT on 10 patients. Following the adaptation, 303 pa-
tients with arthritis completed the OENAT and the data
were subjected to Rasch analysis to assess the construct
validity and reliability of the translated tool. The validated
OENAT was then used in the cross-sectional survey to as-
sess the relationship between educational needs, disease
activity and function.
Participants
Patients with RA and HOA diagnosed according to the
American College of Rheumatology (ACR) criteria [12,13],
and patients with PsA diagnosed according to the criteria
described by Moll and Wright, and by McGonagle et al.
[14] were asked to participate in this study. Participation
was voluntary and ethical approval was obtained from
the ethical committee and internal review board of the
Medical University of Vienna, Austria. Patients gave written
informed consent to participate in the study and agreed
that the findings of the study will be published in a scientific
journal. Each patient was then asked to complete the
OENATat a routine visit to the rheumatology outpatient
clinic. Patients were excluded if they (a) had any other
rheumatic or neuromotor disease, (b) were unable to
understand the language or study procedures or (c) were
unwilling to participate.
Assessments
The ENAT is a self-report questionnaire designed to assess
the educational needs of patients with rheumatic diseases
[11]. It was originally developed with patients and practi-
tioners in the UK and comprises 39 items grouped into the
following seven domains: managing pain (six items), move-
ment (five items), feelings (four items), arthritis process
(seven items), treatments (seven items), self-help measures
(six items) and support systems (four items) [10]. Items
consist of a statement providing a Likert scale ranging
from 0 (not important at all) to 4 (extremely important).
The OENAT is presented in the (see Additional file 1).
In addition to the OENAT, patients completed the
German version of the Health Assessment Question-
naire (HAQ) [15,16], and the Clinical Disease Activity
Index (CDAI) was calculated for the RA and PsA
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and the Disease Activity Index for PsA (DAPSA) [17] for
the PsA group. All variables needed were recorded during
the routine clinical visit at the rheumatology outpatient
department.
Statistical analyses
Rasch analysis was used to assess the internal construct
validity of the OENAT and its invariance to age, gender,
disease duration, educational background and diagnosis.
The Rasch model specifies how data should look in order
to comply with fundamental requirements of measure-
ment, for example, unidimensionality. The observed data
from the ENAT were measured against the Rasch model
to assess how well they fit the model. The fit-to-Rasch
model implies criterion-related construct validity, reliability
and statistical sufficiency [18], thus, ordinal data from a
questionnaire can be converted into interval scale and
analyzed using parametric statistics [19].
Differences in educational needs were explored across
gender and age groups, split at the median, and patients
with different disease duration and educational back-
grounds. The relationships between educational needs and
disease activity and physical functioning were assessed for
the RA and PSA cohorts. Mean differences (MD) and
Pearson correlation (rp) with the corresponding 95% CI
were calculated, where MD of 0.2, 0.5 and 0.8; and r of 0.1,
0.3 and 0.5 represented small, moderate and large differ-
ences in correlations, respectively [20]. All analyses were
performed using SPSS software version 17 [21].
Results
Demographic data
In total, 303 patients participated in our study, of whom
130 had RA, 125 PsA and 48 HOA. Their demographic
data were similar to the population of patients in their re-
spective diagnostic groups [1] (Table 1). There were sig-
nificant differences in mean age between the three cohortsTable 1 Demographic data of the three diagnostic cohorts
Female, n (%)
Age, years, mean (SD)
Disease duration, years, mean (SD)
Educational background Basic, n (%)
Secondary, n (%)
Above, n (%)
Interest in receiving education
How much information? None, n (%)
Some things, n (%)
A lot of things, n (%)
Everything, n (%)(F(2) = 19.08, P <0.001): patients with HOA were older
than the other two groups. There were no significant differ-
ences in disease duration (F(2) = 1.10, P = 0.33). The major-
ity of patients (above 70%) in each group expressed interest
in receiving education about their disease (Table 1).
Internal construct validity and unidimensionality
of OENAT
Rasch analysis of the OENAT revealed that the seven do-
mains of the OENAT formed a unidimensional scale, sug-
gesting the use of domain scores rather than individual
item scores. In addition, the OENAT worked consistently
across patients with different ages, gender, disease dur-
ation and educational backgrounds. The ordinal data from
the OENAT were then converted into interval scale (for
Rasch-transformed values see Additional file 2) and ana-
lyzed using parametric statistics [19].
Educational interest and relationship to other variables
Table 2 summarizes the educational needs of people with
RA, PsA and OA by gender, age, disease duration and edu-
cational background. The significant results are indicated
by asterisks in the table. Gender appears to have an effect
on educational needs in all the three cohorts. In the RA
group, female patients expressed higher educational needs
than their male counterparts in movement (P = 0.04) and
feelings (P = 0.03). Like those in the RA group, female pa-
tients with PsA scored higher on movement (P <0.01) and
feelings, (P <0.01). Interestingly, female patients in the
HOA group had significantly higher scores on all domains
except on the movement domain. Age had effects on the
PsA cohort only, where older patients with PsA scored
higher than their younger counterparts in the pain domain,
(P = 0.05). Disease duration had significant effects on the
RA group where patients with longer disease duration
(>5 years), expressed higher educational needs in move-
ments, (P <0.01). Educational background had effects in
the PsA but not the other cohorts. Patients with basicRA PsA HOA
98 (75%) 56 (45%) 40 (83%)
56 (13.6) 51 (10.5) 64 (7)
11 (9) 11 (10.9) 14 (9.1)
46 (35%) 32 (26%) 21 (44%)
50 (39%) 66 (53%) 17 (35%)
31 (23.8%) 23 (18.4%) 9 (18.8%)
91 (70%) 93 (74%) 81 (89%)
6 (4.6%) 3 (2.4%) 2 (4.2% )
24 (18.5% ) 17 (13.6% ) 5 (10.4%)
24 (18.5%) 34 (27.2%) 5 (10.4% )
74 (57%) 71 (56.8%) 36 (75% )
Table 2 Summary of educational needs across diagnostic groups
Diagnoses Domains Age Gender Disease duration Educational background
Older,
mean
(SD)
Younger,
mean
(SD)
MD
(95% CI)
P-
value
Male,
mean
(SD)
Female,
mean
(SD)
MD
(95% CI)
P-
value
Longer,
mean
(SD)
Shorter,
mean
(SD)
MD
(95% CI)
P-
value
Basic,
mean
(SD)
Higher,
mean
(SD)
MD
(95% CI)
P-
value
A
n = 130)
Pain 15.13
(5.29)
15.42
(5.11)
−0.28
(−2.24,1.67)
0.772 14.95
(4.89)
15.4
(5.24)
−0.45
(−2.75, 1.83)
0.693 15.31
(5.10)
14.48
(5.15)
0.83
(−1.51, 3.17)
0.484 15.39
(5.17)
15.12
(5.06)
0.27
(−1.93, 2.47)
0.810
Movement 11.50
(5.05)
11.63
(5.32)
−0.12
(−2.00, 1.75)
0.894 9.85
(5.77)*
12.12
(4.89) *
−2.27 0.040* 12.20
(4.91)*
9.02
(5.38)*
3.17
(0.99, 5.35)*
0.005* 12.05
(4.94)
10.08
(5.78)
1.97
(−0.18, 4.12)
0.073
(−4.45, -0.10)*
Feelings 8.38
(5.18)
9.14
(4.27)
−0.75
(−2.44, 0.93)
0.382 7.23
(4.80)*
9.33
(4.55)*
-.2.10 0.033* 9.17
(4.72)
7.42
(4.59)
1.75
(−3.02, 2.35)
0.087 9.00
(4.60)
8.18
(4.83)
0.82
(−1.09, 2.75)
0.396
(−4.04, -0.17)*
Arthritis 21.96
(5.28)
22.38
(5.38)
−0.42
(−2.36, 1.51)
0.677 21.62
(5.30)
22.44
(5.34)
−0.82
(−3.07, 1.42)
0.469 22.19
(5.54)
21.75
(4.66)
0.44
(−1.85, 2.73)
0.704 22.80
(4.84)
20.82
(5.79)
1.98
(−0.19, 4.15)
0.074
Treatments 18.38
(6.00)
18.26
(5.89)
0.11
(−2.20, 2.41)
0.923 16.83
(5.67)
18.87
(5.94)
−2.03
(−4.66, 0.59)
0.127 18.19
(5.83)
18.53
(6.43)
−0.33
(−3.02, 2,35)
0.807 18.39
(5.41)
18.09
(7.22)
0.30
(−2.28, 2.89)
0.816
Self-help 16.05
(5.33)
16.67
(5.06)
0.97
(−2.54, 1.30)
0.536 15.57
(4.80)
16.71
(5.24)
−1.13
(−3.33, 1.07)
0.311 16.45
(5.05)
16.11
(5.53)
0.33
(−1.87, 2.53)
0.765 16.51
(5.24)
16.20
(4.95)
1.04
(−0.57, 2.67)
0.78
Support 7.45
(4.10)
7.73
(3.72)
−0.28
(−1.71, 1.15)
0.700 6.93
(3.77)
7.86
(3.92)
−0.93
(−2.62, 0.75)
0.276 7.94
(3.90)
6.41
(3.74)
1.52
(−0.13, 3.19)
0.072 7.82
(3.79)
6.78
(4.06)
1.04
(−0.57, 2.67)
0.20
Total
ENAT
Score
96.61
(30.18)
101
(29.69)
−5.20
(−17.79,7.38)
0.412 91.18
(31.71)
102.81
(28.84)
−11.63
(−25.77, 2.51)
0.106 101.09
(29.95)
93.85
(30.00)
7.24
(−6.98,21.47)
0.314 109.92
(28.04)
96.06
(34.56)
4.86
(−9.10,18.83)
0.49
sA
n = 125)
Pain 17.73
(4.81)*
15.50
(4.80)*
2.23
(0.03, 4.43)*
0.050* 15.20
(5.25)
16.89
(4.09)
−1.69
(−3.49, 0.10)
0.065 16.29
(4.88)
14.87
(4.64)
1.41
(−0.69, 3.51)
0.186 16.17
(0.48)
15.51
(1.31)
0.66
(−1.71, 3.04)
0.581
Movement 10.75
(4.91)
10.39
(5.37)
0.35
(−1.93, 2.65)
0.760 9.15
(5.34)*
11.86
(4.86)*
−2.70 0.005* 10.65
(5.20)
9.65
(5.25)
1.00
(−1.17, 3.18)
0.365 11.03
(5.00)*
7.90
(5.92)*
3.12
(0.69, 5.56)*
0.012*
(−4.59, -0.82)*
Feelings 9.46
(3.82)
9.17
(4.50)
0.28
(−1.58, 2.16)
0.762 7.99
(3.96)*
10.31
(4.76)*
−2.31 0.004* 9.20
(4.21)
8.90
(4.96)
0.29
(−1.53, 2.11)
0.753 9.48
(4.46)
7.74
(4.03)
1.74
(−0.31, 3.79)
0.096
(−3.89, -0.73)*
Arthritis 21.40
(4.17)
20.67
(4.92)
0.72
(−1.38, 2.83)
0.491 20.22
(4.85)
21.43
(4.66)
−1.21
(−2.97, 0.53)
0.171 21.10
(4.63)
20.15
(5.04)
0.95
(−1.03, 2.94)
0.343 21.39
(4.60)
18.60
(4.40)
2.79
(0.51, 5.07)
0.017
Treatments 19.16
(4.25)
17.40
(5.81)
1.27 (0.77,
4.28)
0.170 16.90
(5.72)
18.77
(5.29)
−1.86
(−3.95, 0.22)
0.079 17.84
(5.55)
17.56
(5.48)
0.28
(−2.07, 2.65)
0.809 18.19
(5.43)
16.12
(5.93)
2.06
(−0.63, 4.77)
0.133
Self-help 17.17
(4.54)
16.23
(4.89)
0.94
(−1.12, 3.01)
0.373 15.84
(5.02)
17.48
(4.42)
−1.64
(−3.39, 0.10)
0.065 16.58
(4.78)
15.88
(4.75)
0.69
(−1.29, 2.68)
0.491 16.66
(4.77)
16.17
(5.21)
0.48
(−1.78, 2.76)
0.671
Support 8.28
(3.16)
7.26
(4.28)
1.02
(−0.80, 2.84)
0.275 6.85
(4.00)
8.15
(4.10)
−1.29
(−2.80, 0.20)
0.091 7.53
(3.89)
7.20
(4.59)
0.32
(−1.39, 2.04)
0.709 7.81
(4.12)
5.97
(3.82)
1.83
(−0.11, 3.78)
0.065
Total
ENAT
Score
95.67
(28.52)
105.76
(24.33)
10.09
(−4.39, 24.58)
0.179 91.23
(28.47)
104.98
(25.37)
−13.74
(−24.89, -2.60)
0.016 98.13
(26.82)
94.14
(30.22)
3.99
(−9.11,17.11)
0.546 99.54
(26.87)
85.88
(31.58)
13.66
(−1.40,28.73)
0.075
Pain 0.399 0.001* 0.883 0.953
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Table 2 Summary of educational needs across diagnostic groups (Continued)
HOA
(n = 48)
15.09
(5.29)
16.78
(3.50)
−1.69
(−5.72, 2.33)
8.22
(5.27)*
17.02
(3.77)*
1.77
(−12.39, -5.18)*
15.14
(5.13)
15.63
(7.26)
−0.47
(−7.01,6.06)
15.69
(5.13)
15.56
(5.30)
0.12
(−4.24, 4.49)
Movement 4.57
(6.21)
2.85
(2.12)
1.72
(−2.00,5.44)
0.356 1.33
(0.87)
4.65
(5.75)
−3.31
(−7.47, 0.83)
0.115 3.74
(5.25)
1.76
(0.41)
1.97
(−4.25, 8.21)
0.524 4.43
(5.86)
2.31
(0.81)
2.11
(−2.11, 6.34)
0.318
Feelings 9.12
(5.34)
9.61
(3.68)
−0.49
(−3.87, 2.88)
0.769 2.64
(4.28)*
10.62
(3.73)*
−7.98 0.001* 8.64
(5.06)
9.84
(2.84)
−1.19
(−7.24, 4.84)
0.690 9.16
(4.81)
9.59
(5.44)
−0.42
(−4.28, 3.42)
0.824
(−10.98, -4.98)*
Arthritis 17.73
(7.62)
20.18
(5.40)
−2.45
(−7.51, 2.61)
0.332 9.43
(8.67)*
20.11
(5.25)*
−10.68 0.001* 17.91
(7.49)
15.16
(0.00)
2.75
(−6.14,11.65)
0.534 18.31
(6.83)
18.64
(8.41)
−0.32
(−5.97, 5.31)
0.907
(−15.58, -5.77)*
Treatments 9.52
(7.63)
9.24
(8.02)
0.28
(−5.45, 6.02)
0.923 3.51
(2.68)*
10.75
(7.76)*
−7.23 0.021* 9.21
(7.80)
6.40
(0.00)
2.81
(−6.48,12.11)
0.542 9.40
(7.34)
9.71
(9.83)
−0.30
(−7.26, 6.64)
0.929
(−13.31, -1.16)*
Self-help 18.98
(4.98)
20.38
(3.20)
−1.39
(−4.54, 1.74)
0.375 14.10
(7.11)*
20.43
(3.08)*
−6.32 0.001* 19.38
(5.00)
17.79
(0.00)
1.59
(−4.14, 4.45)
0.590 19.57
(4.65)
18.73
(4.11)
0.83
(−2.76, 4.44)
0.641
(−9.58, -3.05)*
Support 4.83
(3.96)
5.99
(3.38)
−1.15
(−3.77, 1.45)
0.375 1.86
(2.02)*
5.80
(3.72)*
−3.93 0.006* 4.62
(3.60)
4.47
(1.96)
0.15
(−4.14, 4.45)
0.942 4.86
(3.59)
6.06
(4.57)
−1.20
(−4.05, 1.64)
0.400
(−6.69, -1.18)*
Total ENAT
Score
77.77
(31.65)
97.82
(21.70)
−20.04
(−48.09, 8.00)
0.155 33.94
(26.77)*
90.82
(21.82)*
−56.88 0.001* 80.02
(34.36)
71.05
(11.10)
8.96
(−32.91,50.84)
0.663 82.17
(29.18)
78.97
(41.83)
3.20
(−27.99, 4.39)
0.835
(−79.42, -34.33)*
MD, mean difference (older-younger for age, male-female for gender, longer-shorter for disease duration and basic-higher for disease duration). P-value ≤0.05 represents significance effects against the null hypothesis on ‘no
difference’. *Statistically significant results. Older/younger age cutoff is based on disease-specific median age; shorter/longer disease duration cutoff is based on disease-specific 25th percentile. RA, rheumatoid arthritis; PsA, psoriatic
arthritis; HOA, hand osteoarthritis; ENAT, Educational Needs Assessment Tool.
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educational background especially on movements (P = 0.01)
and arthritis process (P = 0.01).
Cross-diagnosis comparison of overall educational needs
was possible between the RA and PsA cohorts because the
OENAT for two cohorts worked on a comparable scale [22].
There were no significant differences of overall educational
needs between the RA and the PsA cohorts (Table 3).
Table 4 shows the correlations between the OENAT do-
mains and disease activity composite measures. In the RA
cohort, there were small but significant correlations between
the Disease Activity Score (DAS28) and the following
OENAT domains: movement (r = 0.24, P = 0.01), feelings
(r = 0.22, P = 0.02), and treatments (r = 0.22, P = 0.03).
However, the OENAT did not correlate with the HAQ in
the RA cohort. In the PsA cohort, all OENAT domains cor-
related with the disease activity indices for PsA (DAPSA
and CDAI). In the same cohort, physical functioning (HAQ)
significantly correlated with the following OENAT domains:
movements (r = 0.38, P < 0.01), feelings (r = 0.33, P = 0.01),
arthritis (r = 0.32, P = 0.01) and support (r = .28, P = 0.03).
Discussion
This was the first study to explore the educational needs of
patients in Austria using a standard instrument (the
OENAT). A high percentage of patients in each disease
group expressed interest in receiving education about their
arthritis. This may be due to the fact that the Austrian
health care system does not routinely offer a structured
form of education to patients with rheumatic diseases. Cur-
rently, education may take place informally and it very
much depends on the willingness of the health professional.
The use of the OENAT may facilitate the identification of
patients' priority needs and enable professionals to provide
relevant education to patients. The OENAT was robust at
summarizing the educational needs of people with RA, PsA
and HOA, and discriminated well between different patient
groups. Although the RA and PsA cohorts were comparable
in their mean age, disease duration and their overallTable 3 Comparison of educational needs between the RA an
Domain (score range)
Psoriatic arthritis, Rheum
mean (SD)
Pain (0 to 24) 14.29 (6.69)
Movement (0 to 20) 9.79 (5.67)
Feelings (0 to 16) 8.68 (4.73)
Arthritis (0 to 28) 19.44 (6.89)
Treatments (0 to 28) 15.90 (7.59)
Self-help (0 to 24) 15.76 (5.90)
Support (0 to 16) 6.83 (4.40)
Total ENAT score (0 to 164) 90.69 (32.11)
MD, mean difference (Psoriatic arthritis cohort minus rheumatoid arthritis cohort). P
‘no difference’.educational needs, the subgroups of patients in those two
cohorts had differences in specific educational needs.
The number of female patient was higher in the RA and
HOA cohorts, while the PsA cohort had almost equal gen-
der representation, which is consistent with gender distri-
bution in the population of patients with the specified
diseases [1]. A slightly larger proportion of women showed
more interest in education about disease management than
men. Men with arthritis have been found to prioritize work
commitments over health concerns [23] and may thus have
expressed less interest in some educational needs. This may
lead to the conclusion that patient education should be tai-
lored to the needs of the participants, which may also in-
clude some gender-specific aspects.
When using the ENAT in clinical practice a clinician is
able to specifically target the individual needs of a patient.
Female patients had significantly more interest in the move-
ment domain (for example, in devices that would help the
patient do practical things, ways to make lifting easier, ways
to save energy, getting enough rest and sleep, and ways to
do things that lessen wear on the joints). A referral to a rele-
vant health professional such as an occupational therapist
may be necessary. Also, the feelings domain (for example,
ways to deal with stress, moods or depression) seems to be
particularly important for female patients and practitioners
may want to proactively assess this domain during consulta-
tions with their female patients. This survey also suggests
that written patient information leaflets should also focus
on specific domains such as movements and dealing with
stress, moods or depression.
Age, disease duration and educational background also
had small effects in subgroups of patients, affecting only one
or two domains. Interestingly, RA patients with longer dis-
ease duration (>5 years) had more educational needs in the
movements domain than those with a shorter duration. This
may be the case for this particular patient group, but educa-
tion on movement may still be as important for patients
with early arthritis to go hand in hand with treatment strat-
egies [24,25].d PsA cohorts
atoid arthritis, Difference
mean (SD) MD (95% CI) t-test p-value
13.40 (6.99) 0.89 (−0.79, 2.58) 1.04 0.30
11.07 (5.62) −1.28 (−2.67, 0.11) −1.81 0.07
8.50 (4.90) 0.17 (−1.01, 1.36) 0.29 0.78
20.65 (7.65) −1.21 (−3.01, 0.59) −1.32 0.19
15.25 (8.79) 0.65 (−1.38, 2.68) 0.63 0.53
13.86 (6.82) 0.91 (−0.67, 2.49) 1.14 0.26
7.00 (4.30) −0.17 (−1.25, 0.90) −0.32 0.75
90.73 (33.6) −0.04 (−8.18, 8.10) −0.01 0.99
-value ≤0.05 represents significance effects against the null hypothesis on
Table 4 Correlations between educational needs, disease activity and function for RA and PsA cohorts
Cohort DAS28 HAQ CDAI SDAI
rp P-value rp P-value rp P-value rp P-value
RA (n = 130) Pain 0.044 0.662 −0.039 0.689 0.030 0.689 −0.083 0.403
Movement 0.235* 0.013* 0.175 0.056 0.139* 0.130 −0.086 0.368
Feelings 0.216* 0.023* 0.109* 0.235 0.054 0.557 −0.005 0.954
Arthritis 0.086 0.375 −0.044 0.635 −0.025 0.786 −0.218* 0.023*
Treatments 0.224* 0.028* 0.014 0.891 0.082 0.409 −0.168* 0.099
Self help 0.169* 0.087 −0.083 0.380 0.011 0.91 −0.024 0.808
Support 0.106* 0.285 0.089 0.342 −0.037 0.697 −0.079 0.418
Total ENAT score 0.174* 0.115 0.019 0.860 0.030 0.777 −0.130* 0.236
DAPSA HAQ CDAI
PsA (n = 125) Pain 0.255* 0.058* 0.113* 0.391 0.260* 0.044*
Movement 0.470* 0.000* 0.384* 0.002* 0.509* 0.000*
Feelings 0.317* 0.013* 0.325* 0.009* 0.303* 0.015*
Arthritis 0.406* 0.002* 0.319* 0.011* 0.422* 0.001*
Treatments 0.330* 0.013* 0.148* 0.259 0.358* 0.005*
Self help 0.361* 0.004* 0.137* 0.276 0.319* 0.010*
Support 0.377* 0.004* 0.283* 0.026* 0.376* 0.003*
Total ENAT score 0.438* 0.002* 0.282* 0.043* 0.455* 0.001*
rp = Pearson correlation, where r = 0.1, 0.3 and 0.5 represent small, moderate and large effects. P-value ≤0.05 represents significance effects against the null
hypothesis on ‘no correlation’; *significant results. RA, rheumatoid arthritis; PsA, psoriatic arthritis; ENAT, Educational Needs Assessment Tool; DAS28; Disease
Activity Score 28; HAQ; Health Assessment Questionnaire; CDAI; Clinical Disease Activity Index; SDAI: Simple Disease Activity Index; DAPSA, Disease Activity Index
for Psoriatic Arthritis.
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correlated with disease activity, which indicated that pa-
tients with more active disease were more interested in
education. Patients may particularly seek education in
states when they are more affected by their disease. The
OENAT could be used to identify time points when pa-
tients are most interested, and therefore, more receptive
in receiving education; showing that this may then be an
ideal opportunity for effective patient education. How-
ever, further research is needed because this study was
cross-sectional and conducted at one time-point without
an educational intervention. Although both the RA and
PsA cohorts had comparable disease duration and mean
age, it was interesting that the OENAT correlated with
physical functioning in the PsA cohort only, the reason
for which also needs further investigation. One reason
could be that PsA can manifest itself in various different
forms, such as monoarthritis, asymmetrical oligoarthri-
tis, symmetrical or asymmetrical polyarthritis [3,26,27].
The limitation of our study is that all our data were col-
lected from convenience samples of patients attending the
clinic at one center in Austria. Cross-diagnosis compari-
sons of educational needs were not possible for the HOA
cohort due to a small number of patients, and the fact that
the OENAT for OA has slightly different properties. An-
other limitation is that we included only the variables of
gender, age, educational background and disease duration,to characterize our patients. However, other variables
could also have influenced the educational needs of pa-
tients, for example, need for support, living situation, co-
morbidities et cetera. Further studies with larger sample
sizes are required for more detailed subgroup analyses, for
example, between women with oligoarthritis and men
with polyarthritis et cetera.
Conclusion
The OENAT has been proved to be robust in assessing the
educational needs of people with RA, PsA and HOA. It is a
useful instrument to guide physicians and health profes-
sionals in the development of targeted patient-centered edu-
cational programs for patients with arthritis. The assessment
of the needs of individual patients and the comparison of
educational needs across subgroups of patients enables clini-
cians and researchers to better understand patients’ needs
and plan education strategies more effectively. Correlation
with disease activity and function, suggest that the OENAT
can enable identification of intervention points, which can be
ideal opportunities for effective patient education.
Educational needs of patients with arthritis vary with per-
sonal characteristics and these should be borne in mind.
They depend on factors such as gender, educational level
and disease duration. By using the ENAT in other coun-
tries [10,28], these findings will enable future comparisons
between these regions and different parts of the world.
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